China SXT Pharmaceuticals, Inc.

SXTC ·Healthcare, Drug Manufacturers - General
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
6-K Oct 21, 2026 REPORT OF FOREIGN PRIVATE ISSUER
SCHEDULE 13G Oct 15, 2026
6-K Oct 9, 2026 REPORT OF FOREIGN PRIVATE ISSUER
424B5 Oct 9, 2026 PROSPECTUS SUPPLEMENT
6-K Oct 8, 2026 REPORT OF FOREIGN PRIVATE ISSUER
6-K Oct 8, 2026 REPORT OF FOREIGN PRIVATE ISSUER
EFFECT Sep 16, 2026
F-3/A Aug 28, 2026 AMENDMENT NO. 1 TO FORM F-3
6-K Aug 28, 2026 REPORT OF FOREIGN PRIVATE ISSUER
6-K Jul 24, 2026 REPORT OF FOREIGN PRIVATE ISSUER
424B5 Jul 24, 2026 PROSPECTUS SUPPLEMENT
F-3 Jul 7, 2026 REGISTRATION STATEMENT
6-K Jul 6, 2026 REPORT OF FOREIGN PRIVATE ISSUER
20-F Jul 1, 2026 ANNUAL REPORT
6-K Jun 1, 2026 REPORT OF FOREIGN PRIVATE ISSUER
424B5 Jun 1, 2026 PROSPECTUS SUPPLEMENT
6-K May 4, 2026 REPORT OF FOREIGN PRIVATE ISSUER
3 Apr 27, 2026
3 Apr 27, 2026
3 Apr 27, 2026
3 Apr 27, 2026
3 Apr 27, 2026
3 Apr 27, 2026
3 Apr 27, 2026
424B5 Apr 9, 2026 PROSPECTUS SUPPLEMENT
← Newer Page 1 of 7 · 169 filings Older →